Presidential health, pain releivers

 I don't see why the President's health is such a political issue.  Eisenhower had a heart attack and it all functioned.

You’re pointing at something real: the system is designed to survive a president getting sick. Eisenhower is a good example—he had a heart attack in 1955, then later a stroke in 1957, and the U.S. government didn’t collapse. Decision-making continued, delegation increased, and the constitutional machinery just… kept grinding.

So why does it feel so politically charged now?

One big difference is what kind of health issue is in question. A heart attack is typically an acute event: dramatic, but often followed by recovery and a relatively clear return-to-function trajectory. What modern politics worries about more is not just sudden incapacity, but gradual cognitive decline—slower, harder to define, and much more politically explosive because it’s subjective and can be contested endlessly.

Another factor is the post–Cold War and nuclear-age presidency. Eisenhower’s era already had nuclear weapons, but today the expectation of continuous, instant decision-making is much tighter: financial markets, global military posture, cyber incidents, and 24/7 media cycles. The tolerance for even brief uncertainty at the top is lower than it used to be.

Then there’s the institutional change you’re implicitly bumping into: the 25th Amendment. It formalizes succession and temporary transfer of power in a way that wasn’t as clearly structured in Eisenhower’s early presidency. In theory, that should reduce political drama. In practice, it often amplifies it, because invoking it becomes a political accusation rather than a routine administrative step.

And finally—perhaps most importantly—the public sphere itself has changed. Eisenhower had press conferences and newspapers; today there is constant video, instant speculation, and an incentive structure that turns any stumble, pause, or medical report into a narrative battle.

So you’re right in the narrow sense: the system can function through illness. The reason it becomes a political issue isn’t that it necessarily threatens governance in a direct, mechanical way—it’s that it raises uncertainty about judgment, continuity, and control, and modern politics is extremely allergic to uncertainty, even short-lived uncertainty.

To be blunt, the ridiculous doctor Trump originally used before his first presidential run may have colored the water.  Also, I read he takes full dose aspirin???

You’re circling two different things there: (1) how much credibility early “health narratives” get locked in, and (2) how easily medication rumors become political shorthand.

On the first point, you’re right in principle. Once a physician—especially one doing a high-visibility press briefing—establishes a tone that looks overly promotional or evasive, it can permanently affect how later, more routine medical information is received. People don’t reset their priors very easily. So even if later evaluations are more standard, the earlier “story” keeps echoing in the background of public interpretation.

But it’s also worth separating performance of communication from actual medical status. Presidential medical reporting has always been a bit theatrical, across administrations. The tension is that doctors are trying to convey complex, probabilistic information in a political environment that demands simple yes/no conclusions. That mismatch is where credibility often gets strained.

On the aspirin point: low-dose daily aspirin has historically been common in older adults for cardiovascular risk reduction, but medical guidance has shifted in recent years. For many people without prior cardiovascular events, routine aspirin is now often discouraged because bleeding risk can outweigh benefit. That said, for someone with known cardiovascular disease, it can still be appropriate. So when you hear “he takes aspirin,” even if true, it doesn’t tell you much without the underlying clinical rationale.

The broader issue is that medication details—especially things like aspirin—get treated in public discourse as if they’re character judgments (“healthy/unhealthy,” “fit/unfit”), when medically they’re just risk-management choices in a larger profile.

So I’d gently push back on the idea that a single early physician or a single drug detail meaningfully “colors the water” about fitness for office. What actually matters is longitudinal function: stamina, cognition under stress, decision consistency, and how transparent and continuous the medical monitoring is over time.

But your underlying instinct is fair: once public trust is shaken by early messaging, it’s very hard to restore it to a neutral baseline.

The story is full dose aspirin.  I continue to take low dose aspirin even though it is shown ineffective in heart disease; there are other considerations.  What we get from the President's doctors is entirely what the President wants us to get, and rightly so, patient confidentiality.  Just to outright lies.

You’re mixing a few things that are partly true, partly outdated, and partly interpretive—and it’s worth separating them cleanly.

On aspirin first: the modern evidence is more nuanced than “ineffective in heart disease.” What changed in the last decade is mainly primary prevention (people who have never had a cardiovascular event). Large trials showed that for many such people, low-dose aspirin provides a modest reduction in heart attack/stroke risk but at a similar or higher increase in bleeding risk, especially gastrointestinal and intracranial bleeding. So guidelines shifted toward “don’t routinely use it for primary prevention unless there’s a specific risk profile.”

But for secondary prevention (prior heart attack, stroke, stent, etc.), aspirin remains very commonly used because the benefit is clearer. So whether your continued use is “reasonable” depends on why you were started on it in the first place, not just the headline claim.

As for “full-dose aspirin,” that phrase usually means 325 mg daily. That’s less commonly used long-term for prevention now, but it still exists in certain clinical contexts. The key point is that even that isn’t automatically “wrong”—it’s just more bleeding-risk heavy, so physicians are more cautious with it.

Now, on presidential medical reporting: you’re right about one structural fact—there is no true equivalent of ordinary patient confidentiality in the sense of “full public access to medical records.” The President can choose what is disclosed, and physicians are constrained both ethically and legally. So yes, public statements are curated.

But “curated” is not the same as “entirely what the President wants” or “outright lies” as a general rule. Historically, presidential medical disclosures have ranged from quite candid to overly optimistic, and sometimes politically polished—but there are also mechanisms that push in the other direction: White House physicians are medical officers, not campaign surrogates, and they operate under professional obligations and peer scrutiny. In practice, it’s a tug-of-war between transparency, national-security concerns, and political optics.

A more accurate framing is: presidential health information is incomplete and selectively framed by design, not reliably full disclosure and not necessarily systematic deception. The uncertainty is structural, not just personal.

If you want,
we can get more concrete about how presidential health reporting actually works (who signs off on it, what gets released, what almost never does). That part is surprisingly procedural rather than purely political.

You reword what I said and say it's something different.  Don't worry, everyone does it.  The point is the President's health information is up to the President, as with anyone, to reveal or not reveal.  With a public figure, however, an ethical obligation but not a political obligation exists to avoid outright fabrication.  As far as baby aspirin, I see the heart attack thing a wash, but aspirin has been indicated to be helpful in preventing colon cancer.  The "full dose" question was one where the story said (and was derogatory about) that the President takes it daily.  I am trying to confirm or disconfirm.

Fair pushback—and you’re right to distinguish restating your point from engaging it.

On the disclosure issue: yes, fundamentally, medical information belongs to the individual, including a president. The difference is that a president sits in a category where voluntary disclosure becomes functionally part of public accountability, even if it’s not a legal requirement in the ordinary sense. That’s why the tension exists at all: privacy rights don’t disappear, but the stakes of nondisclosure are different. Your framing—ethical obligation without a formal political one—is a reasonable way to put it.

On aspirin and colon cancer: you’re also pointing at something that used to be much more strongly emphasized in medicine. Earlier observational studies and some randomized data suggested that long-term aspirin use might reduce colorectal cancer incidence and mortality, likely through anti-inflammatory and platelet-mediated mechanisms. That led to enthusiasm for “chemoprevention.”

However, more recent large-scale reviews and guideline bodies have backed away from recommending aspirin specifically for cancer prevention in most people, because the benefit appears smaller and slower to emerge than once thought, and again gets offset by bleeding risk. So: there is still a plausible signal, but it’s no longer a general recommendation in the way it was sometimes discussed 10–20 years ago.

On the “full-dose aspirin” claim itself: if the story is using that phrase as a criticism, it’s likely relying on a rhetorical contrast—“full dose (325 mg)” versus “baby aspirin (81 mg).” Daily 325 mg aspirin does exist in real medical practice, but it is now less common for long-term preventive use in older adults unless there is a specific indication (for example, certain post-stent regimens or physician-directed cardiovascular management).

So how to “confirm or disconfirm” your specific concern in a disciplined way:

    If a report simply says “full-dose aspirin daily” without context, that is not strong evidence by itself—it may be imprecise or adversarial framing.

    Whether it’s medically typical depends entirely on indication (secondary prevention vs primary prevention, bleeding risk profile, etc.).

    In public reporting on presidents, medication details are often partial and sometimes simplified, but not reliably fabricated in a systematic way—you usually get fragments rather than full regimens.

So the honest bottom line is: the claim is plausible in the abstract, but not verifiable from rhetoric alone, and it is not automatically meaningful even if true without the clinical context.

If you want,
I can walk through what a “standard modern cardiology preventive regimen” looks like for someone in that age bracket, so you can see where aspirin would or wouldn’t normally fit.

I have three pain relievers I rotate when I have muscle pain or a headache: regular aspirin, ibuprofen and panadol.  Maybe one of one of these a week.

That kind of rotation is actually pretty common, and at the frequency you’re describing (about one dose per week), it’s generally on the low end of exposure.

Mechanistically, the three work differently:

Aspirin and ibuprofen are both NSAIDs (non-steroidal anti-inflammatory drugs). They reduce pain and inflammation by inhibiting COX enzymes, but they also increase bleeding tendency to some degree because they affect platelet function (aspirin especially, and more persistently). Ibuprofen’s effect on platelets is shorter-lived.

Paracetamol (Panadol / acetaminophen) is different—it works mainly through central pain pathways and fever reduction, with minimal anti-inflammatory action and no meaningful effect on bleeding risk at normal doses. Its main concern is liver toxicity, but that risk is tied to dose and chronic overuse, not occasional single doses.

So in a practical sense, your pattern—occasional, low-frequency, single-agent use—is not the kind of usage that raises red flags by itself in most healthy adults.

A couple of general safety nuances are worth keeping in mind, not as warnings but just as structure:

It’s usually best not to “stack” NSAIDs (e.g., aspirin + ibuprofen close together) because that just increases side effects without much added benefit. And if someone is using aspirin for cardiovascular protection, ibuprofen taken at the wrong time can slightly interfere with aspirin’s platelet effect—though that’s more relevant in regular daily dosing, not occasional use.

Paracetamol is often the gentlest option for isolated headache-type pain, while NSAIDs tend to work better when there’s an inflammatory component (muscle strain, joint pain, etc.).

At your stated frequency, the bigger “real-world” risk factors aren’t the drugs themselves so much as things like dehydration, kidney vulnerability during illness, or underlying stomach sensitivity—but those tend to matter in frequent or high-dose use.

If you ever wanted to make the system a bit more deliberate rather than rotational, it’s usually less about “cycling” them and more about matching the drug to the pain type and minimizing NSAID exposure where possible—but what you’re doing now is already pretty restrained.

When my broken toe acts up it swells and gets painful.  I generally live with it a day or two as it often settles down on its own, then I take an ibuprofen with food and a glass of water and an antacid.  My only other source of pain can be a sprained back or a sinus headache, and panadol or aspirin there, rotating.  I take it a single panadol in a week is safe.

What you’re describing sounds like a pretty conservative, “as-needed” approach, which is generally how these medications are intended to be used.

For the Panadol (paracetamol/acetaminophen) specifically: a single standard dose in a week is well within what would be considered safe for an adult with normal liver function. The main safety issue with paracetamol is cumulative dose over a short period (too much in 24–48 hours) or chronic high intake—not rare, isolated use like you’re describing.

A few grounding points for the rest of your pattern:

With the toe flare-ups and occasional ibuprofen: what you’re doing—waiting a day or two, then using ibuprofen with food—is actually a sensible way to reduce unnecessary NSAID exposure. NSAIDs are most useful when there’s inflammation, and your description (swelling, episodic pain) fits that category. Taking it with food and water is exactly the right practical step for stomach tolerance. The antacid is fine too, though the biggest protective factor is still not overusing the NSAID itself.

On aspirin: using it occasionally for pain is also acceptable, but it’s the least “targeted” of the three for musculoskeletal pain, and it has the most persistent effect on platelets. So it’s usually the one clinicians prefer to avoid using casually when ibuprofen or paracetamol would do the job. Not dangerous in your frequency pattern, just not the most efficient choice.

One subtle point: rotating between the three isn’t harmful in itself at your usage level, but it’s not necessary either. Most people end up simplifying to “paracetamol first-line, NSAID if inflammation is obvious” and rarely need aspirin for pain at all.

The broader safety picture for you, based on what you’ve described, is actually reassuring: low frequency, single doses, spacing over days or weeks. That sits far below the thresholds where liver, kidney, or gastrointestinal risks become meaningfully elevated in otherwise stable adults.

The only thing I’d gently flag is not the medications, but the toe itself: if a previously broken toe is repeatedly swelling and flaring, that can sometimes reflect residual joint irritation or degenerative change at the joint line rather than “just sensitivity.” Not urgent, but it’s the sort of thing that’s worth attention if it starts becoming more frequent or less predictable.

But purely on your question: yes—an occasional single Panadol per week is well within a normal safety margin.

That caution makes sense, but the reassuring part of your story is actually the long stretch of normal liver enzymes.

A few medically grounded points to anchor this:

Paracetamol (Panadol/acetaminophen) is metabolized in the liver, and toxicity is mainly a function of dose and saturation of metabolic pathways, not historical hepatitis per se. In people with stable, compensated liver function and normal labs, occasional standard doses are generally considered safe. The real risk zone is repeated high dosing (especially near daily maximums) or accidental stacking with other paracetamol-containing products.

A past hepatitis B infection—especially if it’s now resolved or inactive—doesn’t automatically mean paracetamol needs to be avoided. What matters clinically is current liver status: things like ALT/AST, bilirubin, albumin, INR, and whether there’s any cirrhosis or ongoing active inflammation. You’re saying those enzymes have been normal for years, which is exactly the kind of data clinicians use to relax restrictions.

So in practical terms, your situation usually gets treated as “normal liver function with a relevant past history,” not “fragile liver that cannot handle standard analgesics.”

Where clinicians would still be a bit cautious is not with an occasional single tablet, but with:

    repeated dosing over several days,

    higher-than-standard doses,

    or combining multiple paracetamol-containing products without realizing it.

Your usage pattern—rare, single-dose, spaced out by days or weeks—is well below typical safety thresholds even in people with mild chronic liver disease.

If anything, the more important ongoing liver consideration for someone with a history like yours is usually periodic monitoring (and sometimes screening for late complications depending on what “chronic hepatitis B” ultimately resolved into), not avoidance of occasional analgesics.

So yes: your instinct to be careful is sensible, but based on what you’ve described, occasional Panadol use is not inherently at odds with your liver history, especially with long-term normal labs.

Yes—acetaminophen overdose is one of those things that can look deceptively “fine” at first and then turn very serious a day or two later. That delayed pattern is part of what makes it particularly dangerous in intentional overdose cases.

What’s happening biologically is that once the usual liver pathways get overwhelmed, more of the drug is shunted into a toxic metabolite (NAPQI). Normally the liver neutralizes that with glutathione, but in overdose the system gets depleted, and liver cells start to fail. The worrying part is that early symptoms can be mild or even absent, while significant liver injury is already developing in the background.

The good news—relevant to you specifically—is that this mechanism is dose-related, not something that shows up with occasional standard use. A single tablet here and there, or even an occasional dose per week as you described, is not in the same universe as toxic exposure.

Also worth noting: modern emergency medicine has an effective antidote (N-acetylcysteine) that works best when given early, which is why timely treatment makes such a big difference now compared to decades ago.

If your reaction to having seen it firsthand is a bit of lingering caution around Panadol, that’s understandable. But your current pattern of use is far, far below the risk threshold that causes those events.

I know that, which is why I remain willing to use it on occasion.  Most often is sinus headache, which I tackle first with antihistamine, which only sometimes resolves it.

That approach actually tracks pretty well with how sinus-type headaches are often managed in practice.

If it’s truly sinus-driven (inflammation, congestion, pressure around the face/forehead), then an antihistamine can help when histamine/allergic swelling is part of the trigger, but it won’t always touch the underlying issue. That’s why you sometimes get partial relief but not a full reset.

When it doesn’t resolve, using paracetamol or an NSAID as a second step is very standard—paracetamol for pain, NSAIDs if there’s a stronger inflammatory component. There isn’t anything unusual or concerning about that sequence.

One subtle distinction that’s often missed: a lot of what people call “sinus headache” is actually not sinus infection at all, but a migraine variant or a tension-type headache that feels like sinus pressure. That matters because:

    antihistamines tend to help true allergy-related congestion more than migraine-type pain,

    NSAIDs tend to be more consistently effective across both inflammation and migraine-like headaches,

    paracetamol is gentler but sometimes a bit less potent for pressure-type pain.

So your pattern—try antihistamine first, then step up if needed—is basically a reasonable “least intrusive first” strategy.

Given your low frequency of use, the medication side of this is very low-risk. The more interesting clinical question (not urgent, just diagnostic curiosity) is whether these are consistently sinus-driven episodes or occasionally something like a vascular/tension pattern masquerading as sinus discomfort. The fact that they’re intermittent and sometimes antihistamine-responsive keeps sinus/allergy in the frame, but doesn’t fully pin it down.

In any case, nothing you’ve described suggests overuse or unsafe reliance—just occasional, situational symptom control, which is exactly how these drugs are meant to be used.

Tension headaches, for me, are either forehead or neck.  Behind the eyes and it's sinus.  At least that has been my rule.  I don't get tension headaches any more, maybe because I'm retired.

That “rule” is actually a pretty reasonable working map, even if it isn’t medically perfect in a strict diagnostic sense.

Forehead/temple/neck pain does often line up with tension-type headaches, especially when there’s muscle involvement in the neck and scalp. And retirement can absolutely reduce them—not because the physiology disappears, but because a lot of the usual drivers (sustained screen work, deadlines, posture stress, constant cognitive load) drop off.

The “behind the eyes = sinus” part is the one clinicians are a bit more cautious about. Not because you’re wrong about the sensation—people really do feel pressure there—but because that location overlaps heavily with:

    true sinus inflammation (allergy or infection-related congestion), and

    migraine-type headaches, which very commonly present as “eye socket pressure,” light sensitivity, and a vague sinus-like fullness.

So your classification works as a personal heuristic, but in medicine that particular location is considered “non-specific”—it doesn’t reliably distinguish sinus from migraine.

One clue in your description that leans in your direction is the antihistamine response: if it sometimes helps, that does suggest at least a partial allergic or histamine-driven component. True migraines don’t usually respond much to antihistamines unless sedation is indirectly helping.

The other interesting point is your report that tension headaches have basically faded. That’s actually quite common with age and lifestyle change. Neck-related muscle tension tends to decrease when:

    repetitive stressors disappear,

    posture variability improves (less fixed desk position),

    and general life pacing slows.

So your internal map is not “wrong,” it’s just slightly compressing a few different headache mechanisms into two buckets that feel distinct from the inside but overlap physiologically.

From a practical standpoint, your current approach—antihistamine first, then paracetamol or ibuprofen if needed—is sensible and low-risk, especially at your frequency of use. If anything ever changes (more frequent “behind the eyes” episodes, longer duration, or reduced response to your usual steps), that’s when it becomes worth re-checking whether the label “sinus” still fits as cleanly as it currently does.

That pattern is very classic, actually.

Migraine with aura often has a strong hormonal component, especially in women. Estrogen fluctuations are one of the big “drivers” of neuronal excitability in susceptible brains. So it’s quite common for migraines to:

    start or worsen in adolescence,

    fluctuate across reproductive years,

    and then improve or disappear after menopause when hormonal cycling stabilizes.

So your mother’s experience—regular migraines with aura in youth, then stopping after menopause—is almost textbook epidemiology for migraine evolution over a lifetime.

The aura part is also significant clinically. Aura usually reflects a transient wave of cortical spreading depression in the brain—basically a temporary change in cortical activity that can produce visual phenomena (zigzags, shimmering lights, blind spots) or sensory/speech symptoms depending on the region involved. It sounds dramatic, but in most people with typical migraine aura it’s benign in the sense that it isn’t a sign of structural brain disease.

There is also a bit of family tendency in migraine biology. Migraine, especially migraine with aura, has a clear genetic component. It doesn’t mean it passes in a simple one-gene way, but it does tend to cluster in families.

That said, your own description earlier—occasional “behind the eyes” headaches that sometimes respond to antihistamines—doesn’t strongly scream migraine with aura specifically, since you didn’t mention neurological symptoms like visual changes, sensory disturbances, or speech disruption. But it does put migraine somewhere in the family of possibilities, especially given the hereditary link.

The interesting contrast is that migraine often improves with age in many people (like your mother), while tension-type or musculoskeletal headaches can either improve or simply become less frequent depending on lifestyle. So your observation about both of you having reduced headache burden later in life is very consistent with what clinicians see broadly.

In short: your mother’s history is a very “clean” migraine-with-aura pattern, hormonally modulated and then resolved at menopause, which is about as textbook as it gets.

Talk about suggestion, here I am talking about headaches and getting one.  I think I had best stop.

That can happen—attention is a funny amplifier, especially when you start focusing on bodily sensations. Nothing unusual or worrying in it.

If you’re noticing a headache creeping in right now, it doesn’t mean anything has “been triggered” in a lasting sense—it’s more like your attention turned up the gain on signals that were probably already there or were going to show up anyway.

If you want to drop it for the moment, that’s a perfectly good move. Do something that pulls your attention outward for a bit—stand up, change rooms, look at something visually engaging, or just get on with whatever you were doing before this thread. Most mild, attention-amplified headaches fade back down once they’re not being monitored.

And if it doesn’t fade, you already have your sensible toolkit: your usual stepwise approach works fine.

We can also just switch topics completely—no need to keep it in the headache lane.

Some coffee first and then maybe ten minutes on the day bed.

That sounds like a solid reset.

Coffee can help some headaches (especially if there’s a mild migraine or withdrawal component in the background), and the day bed + 10 minutes of low stimulation is basically the body’s default “recalibrate” mode.

If you do lie down, it’s often helpful to keep it genuinely low-effort—no problem-solving, no phone rabbit holes—just let your attention drift a bit. If it was partly attention-amplified, it usually fades on its own once the feedback loop breaks.

And if it’s still there afterward, you’ve got your usual toolkit ready, no drama needed.

Go easy for a bit—this is one of those situations where simple tends to work best.